The three major retroviral genes, gag, pol, and env, are all expressed as polyproteins which are proteolytically processed during the late stages of virion particle formation (2) . Genetic and biochemical evidence indicates that proteolysis of gag and pol gene products is carried out by a protease (PR) encoded by the retroviral provirus (3, 5, 9, (14) (15) (16) (20) (21) (22) . Viral genomes defective in PR are capable of producing virions, but these are of immature morphology and they are not infectious. The major Gag polyprotein of human immunodeficiency virus type 1 (HIV-1), the retrovirus most commonly associated with human AIDS, is P655ag. The cleavage products of Pr55gag include the matrix protein p17 (MA), the capsid protein p24 (CA), the nucleocapsid protein p7 (NC), and the C-terminal product p6. HIV-1 pol is expressed as a Gag-Pol fusion protein, Pr1609a9P°, via a ribosomal frameshift mechanism (13) bypassing translational termination at the gag-pol boundary. The pol region is processed to four mature products, protease plO (PR), the two subunits of reverse transcriptase p66 and pSi (RT) , and integrase p32 (IN).
The structure of the HIV-1 PR has been determined with and without bound substrate (25-27, 31, 33) . PR is an aspartyl protease which differs from cellular proteases of this class in that two identical protease monomers must associate symmetrically to form the substrate binding cleft (26) . This work provides a biochemical explanation for the observation that PR activation does not occur prior to virion assembly. PR is translated as part of the Gag-PR polyprotein, and activation only occurs after dimerization of the Gag-PR polyprotein at the time of virion assembly.
PR substrate recognition is highly specific; only a few unique sites in the Gag and Gag-Pol precursor proteins are cleaved. Most of the specificity is provided by four amino * Corresponding author.
acids on either side of the scissile bond that are recognized by flaps present on each monomer of PR (4, 18, 22, 26, 31) . Detailed analysis of multiple PR cleavage sites has revealed no simple consensus sequence for PR substrate recognition, but certain general rules have been deduced (28) . On the basis of the amino acid at position P1', there are at least two general classes of substrate recognition sequences. It has been suggested that the differential recognition of these sites may be responsible for the different rates of cleavage observed for the various recognition sites in the Gag and Gag-Pol precursor proteins (7, 10, 28) .
Active HIV-1 PR has been successfully expressed in bacteria by several groups (5, 11, 23) . Thus, bacterially expressed PR can dimerize when synthesized alone, without Gag. In addition, bacterially expressed PR from HIV-1 has been shown to be active when imbedded in a precursor protein (5, 6, 11, 17) . Active Rous sarcoma virus PR can also be expressed as a precursor polyprotein; however, the PR activity of the polyprotein is much less than that of the excised PR (1, 19) .
We previously described the PR activity of a Gag-PR fusion protein expressed in bacteria (24) . We reasoned that this construct might be an interesting substrate for mutagenesis in that PR activation might be used as a readout for polyprotein multimerization. Using this expression plasmid as a substrate for mutagenesis, we have constructed a panel of linker insertion mutations distributed throughout gag and assayed the effect of these mutations on the ability of the expressed mutant Gag-Pr polyproteins to activate PR and to cleave the substrate.
Plasmid pT7HG(Pro+) encodes native HIV-1 Pr55gag and a Gag-Pol fusion protein which extends 533 nucleotides into the pol coding sequence (24) . This plasmid contains the complete pro and produces active PR after induction by standard methods with isopropyl-,-D-thiogalactopyranoside (IPTG); lysates from pT7HG(Pro+)-transformed bacteria contain predominantly the Pr55gag cleavage products, p41, p24/25, and p17, as indicated by Western immunoblotting with monoclonal anti-p24 or anti-p17 antibodies (Fig. 1, lane  2) . A plasmid with a deletion in the PR coding sequence, pT7HG(Pro-), produces the full Pr55a&a (Fig. 1 , lane 1) as well as several C-terminal cleavage products formed by bacterial proteases. The identity of these breakdown products was previously determined with a panel of monoclonal antibodies (24) .
For the construction of linker insertion mutations, standard recombinant DNA technology was employed (30) . pT7HG(Pro+) was partially cleaved with one of several restriction endonucleases (AluI, DdeI, DraI, HaeIII, NlaIV, or RsaI) or cut to completion with PvuII. The resulting linear molecules were purified by agarose gel electrophoresis. When necessary, the ends of the linear products were made blunt ended by treatment with the Klenow fragment of DNA polymerase I, and the linear DNA was then ligated with T4 DNA ligase to a nonphosphorylated oligonucleotide linker containing tandem XhoI sites (5'-CTCGAGCTCGAG-3'). The resulting linear molecules which possessed singlestranded linker sequences at either end were allowed to anneal and used to transform bacteria to ampicillin resistance. Clones were screened for the presence of a XhoI restriction site, and the position of each insertion was determined by restriction mapping.
Twenty-seven linker insertion mutations were obtained (Table 1) . Two were located withinpro coding sequence, and (24) . Grossly, the level of expression of each mutant protein was comparable to that of the wild type. Precursor protein processing was revealed by the presence of the expected PR cleavage products.
The two linkers in PR coding sequence completely obliterated processing of Pr55gag (Fig. 1, lane 5) . Of the two, mutant A2315 contains an insertion near the active site of the enzyme. Mutant A2462 contains an insertion in a more C-terminal region, where only conservative substitutions were found in different laboratory isolates (8) .
The majority of the linkers within the gag coding sequence had no effect on PR activity. Six of the linker insertion mutations, however, produced a substantial reduction in PR activity, globally affecting all cleavage sites in Gag (Fig. 1,   lane 4) . The locations of the linker mutants and the corresponding phenotypes are summarized in Fig. 2 Four selected mutant constructs with linker insertion mutations in the gag coding sequence (A906, A975, R1509, and A1906) were modified to disrupt pro. DNAs were cleaved with the restriction endonuclease BclI, treated with Klenow fragment of DNA polymerase, and cyclized with T4 DNA ligase, disrupting the reading frame of pro. Western blots performed with protein from bacteria transformed with these plasmids confirmed that there was no longer active viral PR and that stable Pr55gag was produced (data not shown). Bacterial cells transformed with these PR-defective plasmids were then cotransformed with pDPT-Pro4 (5), which expresses the HIV-1 PR from the PL promoter. The apparent toxicity of the PR made it necessary for us to first transform the bacteria with a third plasmid, pcI857 (29) , which expresses a thermosensitive mutant of the lambda cI repressor. Thus, Escherichia coli was sequentially transformed to kanamycin, ampicillin, and chloramphenicol resistance with pcI857, then with pT7HG(Pro-) or mutant derivatives, and then finally with pDPT-Pro4 (Fig. 3) . All cultures were grown at 30°C until the time of protein induction. Protein was induced over a 3-h period by the A addition of IPTG at 42°C, and induction was monitored by Western blot.
Mutants A906, A975, R1509, A1906 were tested for the ability to be cleaved by PR provided in trans (Fig. 4) . These four mutants, two of which were poorly cleaved in the previous assay (A906 and R1509), were cleaved by trans PR as efficiently as wild type. This demonstrates that the Gag polyproteins which contain these linker insertion mutations are capable of being cleaved normally when active viral PR is provided in trans. Thus, the most likely mechanism by which the mutants A906 and R1509 affect Gag cleavage in the Gag-PR setting is by disrupting PR activation, perhaps by inhibiting polyprotein dimerization. Alternatively, it is possible that these mutations disrupt PR activation by altering the conformation of the entire precursor polyprotein. Though not tested directly, we believe that the other mutations which were disruptive of protease provided in the Gag-Pr setting may block PR activation by the same mechanism as mutants A906 and R1509. To distinguish between these possible explanations it will be necessary to see whether our mutations affect virion assembly and PR function in vivo.
The three-dimensional structure of retroviral Gag polyproteins and how they self-associate to form a particle are not known. If our assay does reflect polyprotein multimerization, our results suggest that several parts of the Gag polyprotein may be involved in multimerization; the major- (12) . Interestingly, as we found in our protease assay, linkers which disrupted incorporation of fusion proteins into particles clustered in the amino-terminal two-thirds of CA.
